Combined oral toxicity of azaspiracid-1 and yessotoxin in female NMRI mice

Type Article
Date 2011-05
Language English
Author(s) Aasen John A. B.1, Espenes Arild2, Miles Christopher O.3, 4, Samdal Ingunn A.3, Hess PhilippORCID5, 6, Aune Tore1
Affiliation(s) 1 : Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, N-0033 Oslo, Norway.
2 : Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, N-0033 Oslo, Norway.
3 : Norwegian Vet Inst, NO-0106 Oslo, Norway.
4 : AgResearch Ltd, Ruakura Res Ctr, Hamilton 3240, New Zealand.
5 : Inst Marine, Oranmore, Galway, Ireland.
6 : IFREMER, Dept Environm Microbiol & Phycotoxins, F-44311 Nantes 03, France.
Source Toxicon (0041-0101) (Pergamon-elsevier Science Ltd), 2011-05 , Vol. 57 , N. 6 , P. 909-917
DOI 10.1016/j.toxicon.2011.03.014
WOS© Times Cited 19
Keyword(s) Azaspiracid-1, AZA1, Yessotoxin, YTX, Marine algal toxins, Absorption, Pathology, Sublethal, NMRI, Mice, LC-MS/MS, oral toxicity
Abstract For many years, the presence of yessotoxins (YTXs) in shellfish has contributed to the outcome of the traditional mouse bioassay and has on many occasions caused closure of shellfisheries. Since YTXs do not appear to cause diarrhoea in man and exert low oral toxicity in animal experiments, it has been suggested that they should be removed from regulation. Before doing so, it is important to determine whether the oral toxicity of YTXs is enhanced when present together with shellfish toxins known to cause damage to the gastrointestinal tract. Consequently, mice were given high doses of YTX, at 1 or 5 mg/kg body weight, either alone or together with azaspiracid-1 (AZA1) at 200 μg/kg. The latter has been shown to induce damage to the small intestine at this level. The combined exposure caused no clinical effects, and no pathological changes were observed in internal organs. These results correspond well with the very low levels of YTX detected in internal organs by means of LC-MS/MS and ELISA after dosing. Indeed, the very low absorption of YTX when given alone remained largely unchanged when YTX was administered in combination with AZA1. Thus, the oral toxicity of YTX is not enhanced in the presence of sub-lethal levels of AZA1.
Full Text
File Pages Size Access
9 1 MB Access on demand
Author's final draft 18 516 KB Open access
Top of the page